{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:21:15Z","timestamp":1780359675434,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004964","name":"European Commission","doi-asserted-by":"publisher","award":["FP7-INNOVATION I HEALTH-F2-2013-602114"],"award-info":[{"award-number":["FP7-INNOVATION I HEALTH-F2-2013-602114"]}],"id":[{"id":"10.13039\/501100004964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_152639\/1"],"award-info":[{"award-number":["310030_152639\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_152912\/1"],"award-info":[{"award-number":["310030_152912\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_140736"],"award-info":[{"award-number":["310030_140736"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roquette Fr\u00e8res"},{"name":"Italian Ministry of Health","award":["GR-2008-1135635"],"award-info":[{"award-number":["GR-2008-1135635"]}]},{"name":"PO CRO Fondo Sociale Europeo Regione Liguria 2007\u20132013 Asse IV \u201cCapitale Umano\u201d"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vph.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T01:14:42Z","timestamp":1430010882000},"page":"197-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Treatment with KLEPTOSE\u00ae CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response"],"prefix":"10.1016","volume":"72","author":[{"given":"Fabrizio","family":"Montecucco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Boero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Pelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Dallegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Fraga-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00ebtitia","family":"Foug\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Elfakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Gassner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rudaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Parissaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Salom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vuilleumier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Poggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2015.04.008_bb0005","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.vph.2015.04.008_bb0010","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/ATVBAHA.108.165423","article-title":"A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice","volume":"28","author":"Braunersreuther","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2015.04.008_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm.1898","article-title":"Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice","volume":"15","author":"Koenen","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.vph.2015.04.008_bb0020","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vph.2015.04.008_bb0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1160\/TH13-06-0448","article-title":"Treatment with angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques","volume":"111","author":"Fraga-Silva","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2015.04.008_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0024-3205(88)90150-6","article-title":"Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives","volume":"43","author":"Pitha","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.vph.2015.04.008_bb0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/1440-1681.12285","article-title":"Systemic administration of 2-hydroxypropyl-\u03b2-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function","volume":"41","author":"Lopez","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.vph.2015.04.008_bb0040","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1194\/jlr.R047837","article-title":"Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin","volume":"55","author":"Vance","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.vph.2015.04.008_bb0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/eurheartj\/ehq521","article-title":"Anti-apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability","volume":"32","author":"Montecucco","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vph.2015.04.008_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.ATV.0000253886.44609.ae","article-title":"Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice","volume":"27","author":"Braunersreuther","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2015.04.008_bb0055","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/eurheartj\/ehr449","article-title":"The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques","volume":"33","author":"Montecucco","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vph.2015.04.008_bb0060","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vph.2015.04.008_bb0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/eci.12327","article-title":"Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis","volume":"44","author":"Montecucco","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.vph.2015.04.008_bb0070","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","article-title":"Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat","volume":"103","author":"Poggi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vph.2015.04.008_bb0075","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1160\/TH13-07-0531","article-title":"Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice","volume":"111","author":"Nencioni","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2015.04.008_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tcm.2007.03.001","article-title":"Regulatory T-cell immunity in atherosclerosis","volume":"17","author":"Mallat","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.vph.2015.04.008_bb0085","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI1216","article-title":"Hypercholesterolemia is associated with a T helper (Th) 1\/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice","volume":"101","author":"Zhou","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vph.2015.04.008_bb0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ni872","article-title":"Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes","volume":"4","author":"Messi","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vph.2015.04.008_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1194\/M900200-JLR200","article-title":"Fatty acids are rapidly delivered to and extracted from membranes by methyl-beta-cyclodextrin","volume":"51","author":"Brunaldi","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.vph.2015.04.008_bb0100","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1471-4159.2006.04017.x","article-title":"Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy","volume":"98","author":"Bar-On","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.vph.2015.04.008_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.vph.2015.04.008_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2015.04.008_bb0115","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2015.04.008_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(07)61088-5","article-title":"Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial","volume":"370","author":"Bots","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2015.04.008_bb0125","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2015.04.008_bb0130","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vph.2015.04.008_bb0135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000160543.84254.f1","article-title":"Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells","volume":"96","author":"Chan","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.vph.2015.04.008_bb0140","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/CIRCULATIONAHA.113.006381","article-title":"Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity","volume":"129","author":"Hilgendorf","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.04.008_bb0145","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1160\/TH12-11-0819","article-title":"CD4+ T cells in atherosclerosis: regulation by platelets","volume":"109","author":"Li","year":"2013","journal-title":"Thromb Haemost"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T01:28:24Z","timestamp":1537666104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"alternative-id":["S1537189115000774"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.04.008","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with KLEPTOSE\u00ae CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}